Vyome (HIND) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
15 Dec, 2025Executive summary
Special meeting will be held virtually for shareholders to vote on three key proposals, including a reverse stock split, warrant exercise approval, and ELOC issuance approval.
Record date for voting is February 18, 2025, with 3,305,087 shares outstanding and eligible to vote.
Board recommends voting FOR all proposals and outlines procedures for proxy voting, revocation, and result announcements.
Voting matters and shareholder proposals
Proposal 1: Authorize a reverse stock split at a ratio between 1-for-2 and 1-for-250, to be determined by the Board within one year.
Proposal 2: Approve exercisability of 2,703,862 warrants and issuance of up to 15,132,975 shares, with a zero exercise price alternative, issued in a February 2025 offering.
Proposal 3: Approve issuance of up to 15,000,000 shares under a $5,000,000 equity line of credit (ELOC) agreement over 36 months.
Shares held by certain investors on the record date are excluded from voting on related proposals.
Board recommends voting FOR all proposals; abstentions count as votes against Proposals 2 and 3.
Board of directors and corporate governance
Board retains discretion to implement or abandon the reverse stock split within one year of approval.
Board may select the split ratio based on market conditions, trading price, and other relevant factors.
Board can issue additional shares post-split without further shareholder approval, except as required by law or exchange rules.
Communication with the Board is facilitated through the company secretary.
Latest events from Vyome
- Net loss increased to $10.5M in 2025; cash runway to June 2027, further funding required.HIND
Q4 202518 Mar 2026 - Shareholders will vote on directors, an equity plan, auditor ratification, and executive pay.HIND
Proxy Filing15 Dec 2025 - Approval sought for reverse split, warrant exercise, and ELOC share issuance to support merger.HIND
Proxy Filing15 Dec 2025 - Shareholders to vote on reverse split, warrant exercise, and ELOC share issuance for Nasdaq compliance.HIND
Proxy Filing15 Dec 2025 - $5.7M cash, $9.2M net loss, positive VT-1953 data, and 2026 regulatory plans for VT-1908.HIND
Q3 202520 Nov 2025